Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.990
-0.010 (-0.50%)
Apr 28, 2026, 4:10 PM AEST
Imricor Medical Systems Revenue
In the year 2025, Imricor Medical Systems had annual revenue of $292.31K USD, down -69.53%. Imricor Medical Systems had revenue of $95.43K in the half year ending December 31, 2025, a decrease of -77.09%.
Revenue
$292.31K
Revenue Growth
-69.53%
P/S Ratio
1,464.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
641.89M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 292.31K | -667.12K | -69.53% |
| Dec 31, 2024 | 959.42K | 343.86K | 55.86% |
| Dec 31, 2023 | 615.57K | -200.44K | -24.56% |
| Dec 31, 2022 | 816.01K | 119.74K | 17.20% |
| Dec 31, 2021 | 696.27K | -5.89K | -0.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cochlear | 2.34B |
| PolyNovo | 139.49M |
| SomnoMed | 118.50M |
| Aroa Biosurgery | 79.26M |
| Compumedics | 58.49M |
| Lumos Diagnostics Holdings | 18.31M |
| 4DMedical | 5.81M |
| EMVision Medical Devices | 5.43M |